SCHEMBL9784672

SCHEMBL9784672

Cc1c([N+](=O)[O-])ccnc1CCl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
TSHR P16473 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HSD17B10 Q99714 1/20 0.36
GAA P10253 2/20 0.35
CYP3A4 P08684 1/20 0.35
PAX8 Q06710 1/20 0.35
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
PDE10A Q9Y233 1/20 0.34
CTSB P07858 1/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8192014 0.83 TDP1 (0.46) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL8498370 0.81 ALDH1A1 (0.42) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL8566533 0.77 ALDH1A1 (0.53) TDP1TSHRALDH1A1KDM4EMAPT
SCHEMBL9501122 0.77 TDP1 (0.50) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL2773204 0.76 TDP1 (0.54) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL5055510 0.75 TDP1 (0.39) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL16856847 0.75 TDP1 (0.39) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL12898049 0.75 TDP1 (0.39) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL29401720 0.74 TDP1 (0.52) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL27643164 0.74 TDP1 (0.52) TDP1TSHRSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103613581-A Preparation method for Dexiansoprazole SHANDONG INST PHARMACEUTICAL INDUSTRY 2014-03-05 CN disclosed
US-4981861-A ANTIULCER HOFFMANN-LA ROCHE INC. (US) 1991-01-01 US disclosed
US-4950677-A ANTIULCER AGENTS HOFFMANN-LA ROCHE INC. (US) 1990-08-21 US disclosed
EP-0304624-A2 Benzimidazol-2-yl-pyridinum compounds F. HOFFMANN-LA ROCHE AG (CH) 1989-03-01 EP disclosed
US-4766133-A ANTIULCER AGENTS HOFFMAN-LA ROCHE INC. (US) 1988-08-23 US disclosed
EP-0214479-A2 Benzimidazol-2-ylpyridinium compounds F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1987-03-18 EP disclosed
US-4634710-A ANTIULCER, ANTISECRETORY HOFFMANN-LA ROCHE INC. (US) 1987-01-06 US disclosed
CN-85103357-A The method for making of tricyclic imidazole derivatives and acid salt thereof 1986-11-12 CN disclosed
EP-0163842-A1 Tricyclic imidazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 1985-12-11 EP disclosed